Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study

PURPOSE: The FIGARO study aims to provide insights on real-world utilization and tolerability of facilitated subcutaneous immunoglobulin (fSCIG) for primary immunodeficiency disease (PID) or secondary immunodeficiency disease (SID). METHODS: This prospective, multicenter, observational study, evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Borte, Michael, Hanitsch, Leif G., Mahlaoui, Nizar, Fasshauer, Maria, Huscher, Dörte, Speletas, Matthaios, Dimou, Maria, Kamieniak, Marta, Hermann, Corinna, Pittrow, David, Milito, Cinzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088636/
https://www.ncbi.nlm.nih.gov/pubmed/37036560
http://dx.doi.org/10.1007/s10875-023-01470-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088636/
https://www.ncbi.nlm.nih.gov/pubmed/37036560
http://dx.doi.org/10.1007/s10875-023-01470-2

Ejemplares similares